News | July 19, 2023
PrecisionLife identifies first detailed genetic risk factors for long COVID
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Survodutide has a novel mechanism of action (agonism of the dual GCG/GLP-1 receptors) that may have direct effects on energy expenditure in the liver in addition to decreasing appetite
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
Olverembatinib is the first and only third-generation BCR-ABL inhibitor approved in China for the treatment of adult patients with tyrosine kinase inhibitors
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Subscribe To Our Newsletter & Stay Updated
